SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Tina Cascone

Tina Cascone

University of Texas MD Anderson Cancer Center, Houston

Dr. Tina Cascone is an associate professor, multidisciplinary section chief, and director of translational research in the Department of Thoracic/Head and Neck Medical Oncology at MD Anderson Cancer Center in Houston, United States. Her physician-scientist program focuses on mechanisms of tumor response and resistance to immunotherapy in non-small cell lung cancer. She has led practice-changing neoadjuvant immunotherapy trials including NEOSTAR and CheckMate 77T, serves as an At-Large Director on the board of the Society for Immunotherapy of Cancer, and holds editorial roles at the Journal for ImmunoTherapy of Cancer and Cancer Immunology Research. She is a frequent speaker at major international thoracic oncology congresses.

Connect

Tina Cascone

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates